All In Biotech

Drug Trial Radar · NCT06715085

PRGF-ENDORET® Infiltrations in the Treatment of Low Back Pain.

Multicenter, Randomized, Single-blind, Controlled Clinical Trial to Evaluate the Safety and Efficacy of PRGF-ENDORET® Infiltrations in the Treatment of Low Back Pain.

Last checked: Nov 20, 2026Latest source record: Feb 6, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

48

Planned (sponsor's estimate)

Start

Jan 23, 2025

Primary completion

Feb 1, 2026

Study completion Feb 1, 2027

Sponsor

Lead sponsor
Biotechnology Institute IMASDIndustry
Sponsor type
Industry
First posted
Dec 4, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Double (participant, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this clinical trial is to evaluate the efficacy of PRGF in reducing pain and improving patients' quality of life. Researchers will compare an experimental drug (Plasma Rich in Growth Factors) to a control corticosteroid solution in saline solution.

Conditions

  • Diseases [C] - Musculoskeletal Diseases [C05

Interventions

  • Plasma Rich in Growth Factors (PRGF)Drug

    The PRGF application consists of three series of infiltrations in the intervertebral disc, epidural space and facets, with a frequency of two weeks.

  • Corticosteroid solution (Celestone Cronodose suspension for injection) in saline solution.Drug

    The corticosteroid solution application consists of two series of infiltrations of solution of corticosteroid (Celestone Cronodose injectable suspension \[betamethasone\]) and saline solution in the epidural space and in the facets, with a periodicity of one month between them.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. To evaluate the efficacy of PRGF in reducing pain and improving patients' quality of life.Time frame: 6 moths follow up

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Clínica Eduardo Anitua

    Vitoria-Gasteiz, Alava, Spain · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.